ArticleClinical rheumatology2025
Clinical characteristics of dyslipidemia in patients with primary biliary cholangitis: a single-center experience in China.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsDyslipidemia is frequently observed among individuals diagnosed with primary biliary cholangitis (PBC), though its specific characteristics remain incompletely defined. This study aimed to examine the lipid profile patterns and medical features of dyslipidemia in people suffering from PBC.
methodsFollowing the classification criteria proposed by the National Lipid Association, dyslipidemia is classified on the basis of abnormal plasma concentrations of high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C). Clinically, it is categorized into simple high TC, simple high TG, mixed hyperlipidemia, simple HDL-C decrease, and simple high LDL-C. In total, 257 individuals diagnosed with PBC who had dyslipidemia were enrolled in the study, along with 78 age- and sex- matched patients with simple dyslipidemia as the comparison group.
resultsIn contrast to the control group, patients with PBC exhibited markedly increased concentrations of HDL-C, TC, and TG, while LDL-C levels were somewhat reduced. Analysis revealed that HDL-C, TC, and LDL-C levels were positively correlated with liver enzyme levels, whereas TG levels showed a negative correlation with bilirubin levels. In terms of clinical classification, patients with PBC had higher rates of simple TC increase and mixed hyperlipidemia, but a lower proportion had isolated LDL-C increase compared with controls. Patients with PBC who had simple high TC and mixed hyperlipidemia showed higher liver enzyme levels than those with simple high TG, while clinical symptoms were similar across groups.
conclusionDyslipidemia in PBC exhibits unique characteristics, indicating a distinct pathogenesis compared to conventional dyslipidemia. These findings highlight the potential benefit of proactive lipid management in supporting liver function. Key Points • Compared with patients who have simple dyslipidemia, dyslipidemia in patients with PBC has distinct characteristics. • Dyslipidemia is clinically associated with liver damage, and correlation analysis showed a relationship between blood lipid levels and liver function.
Indexed as
Identifiers
40911102What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.